Comparing the effects of 8-week treatment with fluoxetine and imipramine on fasting blood glucose of patients with major depressive disorder

Journal of Clinical Psychopharmacology

Volumn 24, Issue 4, 2004, Pages 386-388

  Ghaeli, Padideh ^a   Shahsavand, Esmail ^a   Mesbahi, Mojdeh ^a   Kamkar, Mahammad Zaman ^a   Sadeghi, Majid ^a   Dashti Khavidaki, Simin ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; FLUOXETINE; IMIPRAMINE;

ADULT; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; FASTING; FEMALE; FLUOXETINE; HUMANS; IMIPRAMINE; MALE; MIDDLE AGED;

EID: 3242686079     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000132441.27854.0d     Document Type: Article

References (6)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8-19.
2. Devane LC. Cyelic antidepressants. In: Murphy EJ, ed. Clinical Pharmacokinetics Pocket Handbook. Bethesda, MD: American Society of Health-System Pharmacy (ASHP). 1993:49-70.
3. Goodnick PJ, Henry JH, Buki VMV. Treatment of depression in patients with diabetes mellitus. J Clin Psychiatry. 1995;56(4):128-135.
4. Daubresse JC, Kolanowski J, Krzentowski G, et al. Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study. Obes Res. 1996;4(4):391-396.
5. O'Kane M, Wiles PG, Wales JK. Fluoxetine in the treatment of obese type 2 diabetic patients. Diabet Med. 1994;11:105-110.
6. Lustman PJ, Freeland KE, Griffith LS, et al. Fluoxetine for depression in diabetes: a randomized, double-blind, placebo controlled trial. Diabetes care. 2000;23:618-623.